Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: A randomised, double-blind study

Journal of Human Hypertension

Volumn 15, Issue 12, 2001, Pages 849-856

  Fernández, Raul ^a   Puig, J G ^b   Rodriguez Perez J C ^c   Garrido, J ^a,e   Redon, J ^d   Fernandez R ^e   Puig, J García ^e   Pérez, J C Rodríguez ^e   Redon J ^e   Mercado, M R Lázaro De ^e   Bueno, J ^e   Tisaire, J ^e   Universitario, H ^e   Calvo, C ^e   Xeral, H ^e   Paz, H La ^e   Castillo, F Martín ^e   General, H ^e   Campdera, F Gómez ^e   Vinuesa, S García De ^e   Maranoin H G ^e   Nieto, J ^e   Vozmeniano, C ^e   Alarcos, H Ntra Sra ^e   Plaza, C ^e   Hortal, L ^e   Negrín, H Doctor ^e   Hidalgo, A Martín ^e   Piedecausa, M ^e   Masia, M ^e   Robles, R ^e   Cristina, H Infanta ^e   Solis J ^e   Ochoa, H Severo ^e   Fernandez C ^e   Nieves, H V ^e   more..

^a Laboratorios Knoll SA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c Hospital Universitario Negrin   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

^e NONE   (Spain)

Author keywords

Combination therapy; Hypertension; Type 2 diabetes mellitus

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL PLUS HYDROCHLOROTHIAZIDE; GLYCOSYLATED HEMOGLOBIN; PLACEBO; POTASSIUM; TRANDOLAPRIL PLUS VERAPAMIL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE REGULATION; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CIRCADIAN RHYTHM; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MONOTHERAPY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; PARALLEL DESIGN; POTASSIUM BLOOD LEVEL; PROSPECTIVE STUDY; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

AGED; ALBUMINURIA; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; INDOLES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROBABILITY; PROSPECTIVE STUDIES; SPAIN; TREATMENT OUTCOME; VERAPAMIL;

EID: 0035681101     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001279     Document Type: Article

References (44)

1. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V
2. Prospective study of microalbuminuria as a predictor of mortality in NIDDM
3. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic patients
4. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus
5. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus
6. Prevention and slowing down the progression of the diabetic nephropathy through antihypertensive therapy
7. Hyperinsulinemia, insulin resistance, and hyperglycemia: Contributing factors in the pathogenesis of hypertension and atherosclerosis
8. Recent progress on the biologic and clinical significance of advanced glycosilation end products
9. NIDDM and its metabolic control predict coronary heart disease in elderly subjects
10. Long-term effects of antihypertensive agents on proteinuria and renal function
11. Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: An update meta-analysis
12. Renal protection in diabetics: An emerging role for calcium antagonists
13. Comparative effects of different antihypertensive treatments on progression of diabetic renal disease
14. Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE-inhibitors
15. National high blood pressure education program working group report on hypertension in diabetes
16. Current issues in treating the hypertensive patient with diabetes: Focus on diabetic nephropathy
17. Report of the expert committee on the diagnosis and classification of diabetes mellitus
18. Antihypertensive treatment efficacy in type 2 diabetes mellitus. Dissociation between casual and 24-hour ambulatory blood pressure
19. Comparative effects of enalapril, atenolol and chlorthalidone on blood pressure and kidney function of diabetic patients afffected by arterial hypertension and persistent proteinuria
20. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
21. The effects of improved glycemic control on complications in type 2 diabetes
22. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS34)
23. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)
24. The association of glycemia and cause-specific mortality in a diabetic population
25. Albuminuria and poor glycemic control predict mortality in NIIDM
26. Long-term glycemic control relates to mortality in type 2 diabetes
27. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study
28. Effects of ACE inhibitors and calcium channel blockers on insulin sensitivity and other components of the syndrome
29. Increased risk of non-insulin-dependent diabetes mellitus in elderly hypertensive patients
30. Effects of antihypertensive therapy on insulin resistance
31. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension
32. Effect of diuretic use on the development of diabetes mellitus: The Framingham study
33. The effect of enalapril with and without hydrochlorotiazide on insulin sensitivity and other metabolic abnormalities of hypertensive patients with NIDDM
34. Preserving renal function in adults with hypertension and diabetes: A consesus approach
35. Enalapril versus bendroflumethiazide in type 2 diabetes complicated by hypertension
36. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
37. The Sixth Report of the Joint National Committee of Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
38. Influence of verapamil on glucose tolerance
39. Inhibition by calcium channel blockers of the glycogenolytic effect of glucagon in perfused rat liver
40. Glucagon and diabetes: A reappraisal
41. Treatment of arterial hypertension in diabetic humans: Importance of therapeutic selection
42. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy
43. Metabolic neutrality of combined verapamil-trandolapril as opposed to beta-blocker-low-dose chlorthalidone in hypertensive type 2 diabetics
44. The effect of anti-hypertensive combination therapy with verapamil SR plus trandolapril vs. Atenolol plus chlorthalidone on glycemic control in hypertensive NIDDM patients